Can Botox Help Treat Hidradenitis Suppurativa?

When people hear “Botox,” they usually think of smoother foreheads, fewer frown lines, and someone saying, “I’m not mad, my eyebrows just can’t physically prove it.” But in dermatology, Botox has a second life as a medical treatment. It can reduce excessive sweating, calm certain nerve signals, and in some situations help with pain. That has sparked an intriguing question for people living with hidradenitis suppurativa, or HS: can Botox actually help treat it?

The honest answer is maybe, for some people, but it is not a standard first-line treatment. The research so far is small, early, and far from definitive. A few case reports and one small randomized pilot study suggest botulinum toxin may improve symptoms, quality of life, and sometimes lesion counts in selected patients. Still, it remains an off-label option for HS, which means it is not FDA-approved specifically for this condition.

That does not mean the idea is silly. It means the science is still catching up. If you have HS and you are curious about Botox, here is what the evidence suggests, where it might fit, and where expectations need to wear a seatbelt.

What Is Hidradenitis Suppurativa, Exactly?

Hidradenitis suppurativa is a chronic inflammatory skin disease that tends to affect areas where skin rubs together, including the underarms, groin, buttocks, inner thighs, and under the breasts. It can cause painful nodules, abscesses, tunnels under the skin, drainage, odor, and scarring. In other words, it is not “just bad acne,” and anyone who says that deserves to be gently handed a dermatology textbook.

HS often flares in warm, moist, high-friction areas. That matters because sweating and rubbing can aggravate symptoms in some people. This is one reason Botox entered the HS conversation in the first place. If a medication can reduce sweating in targeted areas, maybe it can also reduce some of the moisture, friction, irritation, and bacterial overgrowth that make flares more miserable.

Why Would Botox Even Be Considered for HS?

Botulinum toxin works by blocking nerve signals. In cosmetic use, it relaxes muscles. In medical dermatology, it can also reduce sweating when injected into the skin. Botox is already FDA-approved for severe underarm sweating, also called primary axillary hyperhidrosis. Because many people with HS struggle in sweaty, high-friction areas, researchers have wondered whether this sweat-reducing effect could indirectly help calm HS symptoms.

There are a few theories behind the idea:

1. Less sweat may mean less irritation

HS often shows up in intertriginous zones, where moisture and friction are basically roommates. If sweating drops, the skin environment may become less irritating for some patients.

2. Less friction may reduce flare triggers

When skin is constantly damp, rubbing gets nastier. Reducing sweat may help lower friction and discomfort, especially in the underarms and groin.

3. There may be a pain benefit

Botulinum toxin has been studied in other painful conditions, and some researchers think it may help modulate pain signaling. That does not make it a miracle shot, but it may partly explain why some HS patients in case reports described pain relief.

4. It may help patients with both HS and hyperhidrosis

This is probably the most logical niche. If a person has HS and also clearly has excessive sweating in the same areas, Botox might address one piece of the problem more directly than it would in someone whose disease is driven mostly by deep inflammation and tunneling.

What Does the Research Actually Say?

This is where things get interesting, but also where the fine print matters.

A systematic review published in 2022 looked at the available clinical evidence for botulinum toxin in HS. The review found only six studies involving 26 patients. That is tiny. It included one randomized controlled trial, one case series, and four case studies. The review concluded that the effectiveness and safety of botulinum toxin for HS remain unknown because the clinical data are still limited and low quality.

Translation: the early signals are promising, but the evidence is nowhere near strong enough to crown Botox as a mainstream HS therapy.

The small randomized pilot study

The most useful study so far was a randomized, double-blind, placebo-controlled pilot trial using botulinum toxin type B. It enrolled 20 patients with Hurley stage I to III HS. At three months, the botulinum toxin group had a significant improvement in Dermatology Life Quality Index scores compared with placebo. The active-treatment group also showed improvement in self-rated health impact, and total lesion counts decreased over time. That is meaningful, especially in a disease where quality of life can take a real beating.

Still, the study was small, single-center, and not large enough to settle the question. Small pilot studies are useful for generating excitement and future research. They are less useful for making grand promises on the internet. The internet, of course, does not always know this.

The case reports and small real-world experiences

Several case reports have described improvement after botulinum toxin injections. One published report described a woman with Hurley stage III HS whose pain improved and whose abscesses and draining sinus tracts improved after repeated botulinum toxin A injections every three months. Other small reports and case series suggest some patients experienced less pain, less drainage, or better quality of life.

That matters because HS is not only about lesion counts. It is also about sitting, walking, exercising, sleeping, wearing clothes comfortably, and existing as a human without feeling like your skin has launched an organized protest.

But case reports have major limits. They do not tell us how often a treatment works, which patients are most likely to benefit, what the best dose is, how long results last in HS, or how it compares with more established treatments. They are clues, not verdicts.

So, Can Botox Help Treat HS?

Yes, it may help some people with HS, especially if their disease is worsened by sweating in specific areas or if they have overlapping hyperhidrosis. But no, it is not considered a proven standard treatment for HS overall.

The best way to think about Botox in this setting is as a selective, off-label adjunct. In plain English, that means it may be something a dermatologist considers when usual treatments are not enough, when symptoms are localized, or when excessive sweating seems to be a major trigger.

It is probably not the first thing most specialists reach for in moderate to severe HS with significant tunneling, widespread inflammation, or scarring. In those situations, medical therapy and sometimes surgery remain the backbone of treatment.

What Botox Cannot Do for HS

Botox may reduce sweat. It may possibly reduce pain or irritation in some patients. But it does not fix the entire inflammatory engine of HS.

That means Botox is unlikely to be enough on its own for people with:

• deep tunnels or sinus tracts,
• extensive scarring,
• frequent abscesses across multiple body areas,
• moderate to severe inflammatory disease that needs systemic treatment.

In these cases, established HS management usually involves a broader strategy that may include topical therapy, oral antibiotics, steroid injections into flaring lesions, hormonal therapy in selected patients, biologics, laser procedures, unroofing, or surgical excision.

How Botox Compares With Standard HS Treatments

If you are wondering where Botox sits on the treatment ladder, the short answer is: off to the side, not at the center.

For milder HS

Doctors commonly use topical clindamycin, antiseptic washes, oral tetracycline-class antibiotics, and lifestyle measures aimed at reducing friction, smoking exposure, and flare triggers. Intralesional steroid injections can help painful, localized inflammatory nodules.

For hormone-sensitive or selected cases

Hormonal therapy such as certain oral contraceptives or spironolactone may help some patients, particularly when flares appear linked to hormonal patterns.

For moderate to severe HS

Biologics are now a major part of treatment. In the United States, adalimumab, secukinumab, and bimekizumab have FDA approval for HS in defined patient groups. These treatments target inflammation more directly than Botox does.

For tunnels, recurrent abscesses, or scarred disease

Procedural treatment matters. Unroofing, laser approaches, and surgical removal of affected tissue can be critical when the disease becomes structurally entrenched in the skin.

That is why Botox usually makes the most sense as a supplement, not a solo act. Think of it as a supporting actor with niche potential, not the blockbuster lead for most HS cases.

Who Might Be a Reasonable Candidate to Discuss Botox With a Dermatologist?

You may want to ask about Botox if several of these apply to you:

• Your HS is concentrated in sweaty areas such as the underarms or groin.
• You also have noticeable hyperhidrosis.
• Your flares seem clearly linked to heat, sweating, and friction.
• You have tried standard HS treatments but still have localized symptoms.
• You and your dermatologist are looking for an add-on approach rather than a complete replacement for established therapy.

You may be a less ideal candidate if your disease is widespread, heavily scarred, dominated by tunnels, or urgently needs systemic control. In that situation, Botox may be too narrow a tool for a very broad fire.

Downsides, Unknowns, and Practical Questions

Even when Botox helps, the result is not permanent. In hyperhidrosis treatment, benefits often last months, not forever, and repeat injections are usually needed. For HS, researchers still do not know the ideal dose, injection pattern, retreatment interval, or which toxin type works best. Some HS studies used type A, while the pilot trial used type B.

There are also practical issues:

• Cost: off-label treatment may not be covered by insurance.
• Discomfort: multiple injections in already tender skin are nobody’s idea of a spa day.
• Limited evidence: your doctor may reasonably prefer established options first.
• Not a cure: symptom improvement does not mean the disease process is gone.

And because HS skin can be inflamed, draining, and painful, injection planning has to be individualized. This is not the sort of thing to improvise after watching two social videos and one suspiciously confident influencer.

Questions to Ask Your Dermatologist

If you want to bring up Botox for HS, ask smart questions:

• Do I seem to have sweating-triggered disease or overlapping hyperhidrosis?
• Would Botox be an add-on treatment or a substitute for something else?
• Which toxin type would you use, and why?
• How often would I need injections?
• What outcomes would we track: pain, drainage, odor, flares, or quality of life?
• Will insurance cover any part of this?
• Am I a better candidate for biologics, laser, unroofing, or surgery instead?

The Bottom Line

Botox may help treat hidradenitis suppurativa in selected patients, especially when sweating seems to be a major aggravating factor. The early evidence suggests possible benefits in quality of life, pain, and lesion burden for some people. But the data are still limited, the treatment is off-label, and it should not be mistaken for a proven mainstream therapy.

For most people with HS, the smartest path is a dermatologist-guided plan that matches the actual pattern of disease. Sometimes that means antibiotics. Sometimes it means hormone therapy or biologics. Sometimes it means laser or surgery. And sometimes, for the right person, Botox may be a reasonable side road worth exploring.

In other words, Botox is not nonsense in HS. It is just not a slam dunk. It is a “promising maybe,” which in medicine is both exciting and mildly annoying.

Real-World Experiences and What the Treatment Journey Can Feel Like

For many people with HS, the idea of trying Botox usually does not come up on day one. It often appears later, after a long stretch of trial and error. Someone may have already cycled through washes, creams, oral antibiotics, steroid injections, dressing changes, clothing changes, and the endless mental math of, “Can I exercise today, or will sweat make this worse?” By the time Botox enters the conversation, it is often because the patient has become very good at noticing patterns. Some people say their worst flares happen when heat, friction, and moisture pile on at once. Under those circumstances, a treatment that reduces sweating can sound less like vanity and more like strategy.

Patients who seem most interested in Botox are often not asking for a miracle. They are asking for less: less rubbing, less stinging, less dampness, less odor anxiety, less pain when they move their arms or walk across a parking lot in July. That distinction matters. In real life, people with HS are often thrilled by improvements that look modest on paper but feel huge in daily living. Sleeping more comfortably, wearing a normal shirt color without panic, making it through a workout, or sitting through a meeting without thinking about drainage every six seconds can be a major win.

Dermatologists, meanwhile, usually think in layers. A doctor may look at Botox not as “the treatment,” but as one possible tool inside a broader plan. In that setting, the experience can feel more realistic and less disappointing. A patient might continue a biologic, keep up wound care, use targeted injections for inflammation, and then try Botox in a sweat-prone zone to reduce one aggravating factor. When expectations are set that way, even partial relief can feel worthwhile.

There is also an emotional side to these treatment discussions. HS is exhausting, and many patients arrive at appointments already braced for another dead end. Hearing that Botox might help some people, but is not guaranteed, can create mixed feelings. Hope is nice. Uncertainty is less fun. That is why the best experiences often come from clear conversations: what problem are we trying to solve, what result counts as success, and how long do we give it before deciding whether it helped?

Of course, not every experience is positive. Some people may go through the cost and discomfort of injections and feel little change in their HS. Others may notice that sweating improves but deeper nodules and tunnels keep doing exactly what they were doing before. That can be frustrating, but it does not necessarily mean the treatment was irrational; it may just mean the disease biology was bigger than the benefit Botox could offer.

The most grounded takeaway from patient experiences is this: Botox seems most useful when the treatment target is specific and the goals are practical. It is not usually the star of the whole HS story. But for the right person, in the right area, at the right time, it may make life noticeably easier. And when you live with HS, “noticeably easier” is not a small thing. It is the kind of result that can make a person feel a little more in charge of their body again, which is sometimes half the battle.